Thermo Fisher outlines a cautious 2026 path, shares backed by solid S&P 500 presence

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-29, 11:06.

Thermo Fisher Scientific (US8835561023) sets up its next earnings steps in a dense calendar for the second half of 2026. The S&P 500 member remains closely watched on the NYSE as investors weigh medical instruments exposure and life-science tools demand in a mixed macro backdrop.

What analyst data shows

Thermo Fisher’s shares trade under the ticker TMO on the NYSE, giving the stock a clear anchor in US large-cap healthcare. The company sits in the medical instruments sector with a focus on life-science tools and services, according to sector classifications used by MarketBeat and other data providers.MarketBeat sector overview for Thermo Fisher

Consensus data compiled by TradingKey points to an overall Buy recommendation for Thermo Fisher shares, with an average price target of around 602.87 US dollars. This implies a meaningful upside from the last closing region in the low 500s, underscoring that sell-side research houses still see value in the long-term earnings path.TradingKey analyst and valuation summary for TMO

Earnings and valuation markers

Thermo Fisher reported trailing twelve-month earnings per share (EPS) of roughly 17.78 US dollars, a figure cited in TradingKey’s data for the stock. At a share price a little above the 513-dollar mark, this translates into a trailing price-earnings ratio in the high twenties, around 28 times earnings on that measure.TradingKey EPS and valuation metrics

With a market capitalization near 190.65 billion US dollars, Thermo Fisher ranks among the larger names in global healthcare equipment and services. The company’s scale is comparable to other diversified diagnostics and tools players such as Danaher or Agilent Technologies, though each group has a different mix between instruments, consumables and services.TradingKey market cap data for Thermo Fisher

The business behind the stock

Thermo Fisher generates revenue from a broad portfolio of laboratory equipment, reagents and analytical instruments used in research, diagnostics and industrial applications. A representative product line is its portfolio of mass spectrometers, which allows laboratories to identify and quantify molecules in complex samples efficiently.

Where the shares trade today

The Thermo Fisher shares (US8835561023) last closed on the NYSE on 2026-06-26 at around 513.03 US dollars, based on TradingKey’s delayed quote, with extended trading indications slightly below that level in the early hours of the next session.

This text is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data were compiled from publicly available sources believed to be reliable but without any guarantee of accuracy or completeness. Investors should conduct their own research or consult a professional advisor before making investment decisions.